Africa: Twice-Yearly HIV Prevention Shot Priced At $40 – – What It Means for South Africa
What’s new From 2027, Indian generics companies and Hetero Labs Dr. Reddy’s will supply lenacapavir, a twice-yearly injectable PrEP with ~96-100% efficacy, for US$40 (R698) per person per year across 120 low- and middle-income countries. South Africa, home to the world’s largest HIV epidemic, is included in the agreement, making the country one of the…
